LncRNA LINC00173 enhances triple-negative breast cancer progression by suppressing miR-490-3p expression
Huijie Fan(Shanxi University), Jing Yuan(Sun Yat-sen University), Xiaofeng Wang(Cleveland Clinic), Xiangyü Li(Jiangsu Province Hospital), Yihui Ma(Wuhan University), Benling Xu(Zhengzhou University), Xingya Li(Zhengzhou University)
Cited by 72
Related Papers
Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-β signaling in regulatory T cells
|Cell Reports|2022|465
High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene
|Cancer Cell|2004|379
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
|Journal of Thoracic Oncology|2021|311
Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study
|The Lancet Oncology|2020|193
Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
|The Lancet Respiratory Medicine|2021|183